Protopic Adherence and Efficacy in Korean Eczema Patient

March 28, 2016 updated by: Pusan National University Hospital
The purpose of this study is to determine whether the dosage of 0.1% tacrolimus ointment applied on unit area of eczema influence the efficacy of treatment.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
      • Busan, Korea, Republic of
        • Department of dermatology, Pusan National University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patient with atopic dermatitis

Description

Inclusion Criteria:

  • at least 19 years of age with a diagnosis of atopic dermatitis
  • treated with protopic 0.1% ointment

Exclusion Criteria:

  • treated with other medication or topical agent
  • skin lesion on the scalp or hand and foot
  • pregnant women/lactating women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
clinical assessments of erythema, scaling, and pruritus
Time Frame: 2 weeks
EASI score
2 weeks
clinical assessments of erythema, scaling, and pruritus
Time Frame: 2 weeks
TIS score
2 weeks
clinical assessments of erythema, scaling, and pruritus
Time Frame: 2 weeks
IGA/PGA score
2 weeks
clinical assessments of erythema, scaling, and pruritus
Time Frame: 2 weeks
DLQI
2 weeks
clinical assessments of erythema, scaling, and pruritus
Time Frame: 2 weeks
itching VAS scale
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Pusan National University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (ACTUAL)

March 1, 2016

Study Completion (ACTUAL)

March 1, 2016

Study Registration Dates

First Submitted

April 24, 2014

First Submitted That Met QC Criteria

April 27, 2014

First Posted (ESTIMATE)

April 29, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

March 30, 2016

Last Update Submitted That Met QC Criteria

March 28, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PUNHDM-adherence

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe